Impossible Foods Tests A Tastes-Like-Meat Patent In Court

MF
Morrison & Foerster LLP

Contributor

Known for providing cutting-edge legal advice on matters that are redefining industries, Morrison & Foerster has 17 offices located in the United States, Asia, and Europe. Our clients include Fortune 100 companies, leading tech and life sciences companies, and some of the largest financial institutions. We also represent investment funds and startups.
Michael Ward spoke to Bloomberg Law about Impossible Foods' recent infringement lawsuit against a competitor that tests Impossible Foods' patented technology for the first time in court...
United States Intellectual Property
To print this article, all you need is to be registered or login on Mondaq.com.

Michael Ward spoke to Bloomberg Law about Impossible Foods' recent infringement lawsuit against a competitor that tests Impossible Foods' patented technology for the first time in court, and is viewed as a test case that could help shape the brand's market-leading patent portfolio.

According to Michael, the patenting activity seen so far is the “tip of the iceberg.”

“The whole healthy eating/plant-based food area is exploding,” Michael added.

Read the full article (subscription required).

Originally Published by Bloomberg Law

Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Morrison & Foerster LLP. All rights reserved

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Impossible Foods Tests A Tastes-Like-Meat Patent In Court

United States Intellectual Property

Contributor

Known for providing cutting-edge legal advice on matters that are redefining industries, Morrison & Foerster has 17 offices located in the United States, Asia, and Europe. Our clients include Fortune 100 companies, leading tech and life sciences companies, and some of the largest financial institutions. We also represent investment funds and startups.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More